| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nrx Pharmaceuticals, Inc. (NRXP) has 0 insiders with recent SEC Form 4 filings, including 1 buy and 1 sell. NRXP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 20, 2018 | Ackerman Richard | President And CEO | Sell | 1,500,000 | $0.00 | - | -87.0% | |
| Nov 29, 2017 | Ackerman Richard | President And CEO | Buy | 22,500 | $10.00 | $225,000.00 | +9.0% |